Guideline adherence for empirical treatment of pneumonia and patient outcome treating pneumonia in the netherlands

Netherlands Journal of Medicine

Volumn 71, Issue 10, 2014, Pages 502-507

  Huijts, S M ^a   van Werkhoven, C H ^a   Boersma, W G ^b   Buijs, J ^c   Buunk, G ^d   Compaijen, C J ^e   van Elden, L J R ^f   Gisolf, J E H ^g   van der Kamp, R ^h   Kluytmans, J A J W ⁱ   Kuipers, B A F ^j   Mager, J J ^k   Oppedijk, B ^l   Palmen, F ^m   Prins, J M ⁿ   van Reemst, B ^o   Silbermann, M H ^p   van Tiel, F H ^q   van der Wall, E ^e   van der Werf, T S ^r   Bonten, M J M ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Location Alkmaar   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d Franciscus Hospital   (Netherlands)

^e Infection and Immunology   (Netherlands)

^f DEPARTMENT OF SURGERY   (Netherlands)

^g RIJNSTATE HOSPITAL   (Netherlands)

^h Zuwe Hofpoort Ziekenhuis   (Netherlands)

ⁱ AMPHIA HOSPITAL   (Netherlands)

^j ISALA HOSPITAL   (Netherlands)

^k ST ANTONIUS HOSPITAL   (Netherlands)

^l Lievensberg Hospital   (Netherlands)

^m CPRLab   (Netherlands)

ⁿ ACADEMIC MEDICAL CENTER   (Netherlands)

^o MARTINI HOSPITAL   (Netherlands)

^p Tergooi Hospitals   (Netherlands)

^q MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF GRONINGEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; MACROLIDE; QUINOLONE DERIVATIVE; TETRACYCLINE;

ADULT; COMMUNITY ACQUIRED PNEUMONIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; PROSPECTIVE STUDY; REVIEW; THORAX RADIOGRAPHY;

EID: 84891872618     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. WoodheadMA, MacfarlaneJT, McCrackenJS, RoseDH, FinchRG. Prospective study of the aetiology and outcome of pneumonia in the community. Lancet. 1987;1:671-4.
2. FarrBM, KaiserDL, HarrisonBD, ConnollyCK. Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax. 1989;44:1031-5.
3. BoersmaWG, DanielsJM, LowenbergA, BoeveWJ, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med. 2006;100:926-32.
4. JokinenC, HeiskanenL, JuvonenH, et al.Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis. 2001;32:1141-54.
5. WoodheadMA, MacfarlaneJT, RodgersFG, LaverickA, PilkingtonR, MacraeAD.Aetiology and outcome of severe community-acquired pneumonia. J Infect. 1985;10:204-10.
6. LimWS, MacfarlaneJT, BoswellTC, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001;56:296-301.
7. DrydenM, HandK, DaveyP. Antibiotics for community-acquired pneumonia. J Antimicrob Chemother. 2009;64:1123-5.
8. SchoutenJA, PrinsJM, BontenMJ, et al. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia. Neth J Med. 2005;63:323-35.
9. FineMJ, AubleTE, YealyDM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New Engl J Med. 1997;336:243.
10. LimWS, van der EerdenMM, LaingR, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377-82.
11. MandellLA, WunderinkRG, AnzuetoA, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27-72.
12. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3): 1-55.
13. ArnoldFW, LaJoieAS, BrockGN, et al. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Arch Intern Med. 2009;169:1515-24.
14. BlasiF, IoriI, BulfoniA, CorraoS, CostantinoS, LegnaniD. Can CAP guideline adherence improve patient outcome in internal medicine departments?Eur Respir J. 2008;32:902-10.
15. DambravaPG, TorresA, VallesX, et al. Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J. 2008;32:892-901.
16. FreiCR, RestrepoMI, MortensenEM, BurgessDS. Impact of guidelineconcordant empiric antibiotic therapy in community-acquired pneumonia. Am J Med. 2006;119:865-71.
17. FreiCR, AttridgeRT, MortensenEM, et al. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther. 2010;32:293-9.
18. MortensenEM, RestrepoM, AnzuetoA, PughJ. Effects of guidelineconcordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med. 2004;117:726-31.
19. GrenierC, PepinJ, NaultV, et al. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and communityacquired pneumonia. J Antimicrob Chemother. 2011;66:1617-24.
20. MarrasTK, JamiesonL, ChanCK. Inpatient care of community-acquired pneumonia: the effect of antimicrobial guidelines on clinical outcomes and drug costs in Canadian teaching hospitals. Can Respir J. 2004;11:131-7.
21. McCabeC, KirchnerC, ZhangH, DaleyJ, FismanDN.Guidelineconcordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009;169:1525-31.
22. MenendezR, FerrandoD, VallesJM, VallterraJ.Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest. 2002;122:612-7.
23. MenendezR, TorresA, ZalacainR, et al.Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med. 2005;172:757-62.
24. MarrasTK, ChanCK.Use of guidelines in treating community-acquired pneumonia. Chest. 1998;113:1689-94.
25. WiersingaWJ, BontenMJ, BoersmaWG, et al.SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. Neth J Med. 2012;70:90-101.